Northwestern Mutual Wealth Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-10,041
Closed -$7K 3060
2020
Q4
$7K Sell
10,041
-831
-8% -$1.77K ﹤0.01% 2313
2020
Q3
$24K Buy
10,872
+562
+5% +$1.6K ﹤0.01% 1752
2020
Q2
$37K Sell
10,310
-809
-7% -$2.92K ﹤0.01% 1543
2020
Q1
$42K Sell
11,119
-3,107
-22% -$10.2K ﹤0.01% 1466
2019
Q4
$43K Buy
+14,226
New +$37K ﹤0.01% 1518

Other funds holding BMY.RT

Northwestern Mutual Wealth Management's BMY.RT Position: Q1 2021 in Review

Northwestern Mutual Wealth Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 10,041 shares — an estimated $7K sold.

Northwestern Mutual Wealth Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $43K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Northwestern Mutual Wealth Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 10,041 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $7K.
  • Northwestern Mutual Wealth Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $43K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2021, filed 14 May 2021.